Key result
Elevated Lp(a) is linked to increased cardiovascular risk in patients with type 2 diabetes.
Why the study?
Patients with type 2 diabetes mellitus commonly have altered lipid levels, prompting an appraisal of the association between lipoprotein(a), the LDL:HDL ratio, and glycemic control in this population.
This narrative review highlights the need for further research to clarify the complex relationship between Lipoprotein(a), the LDL:HDL ratio, and glycemic control to improve cardiovascular risk modification in patients with Type 2 Diabetes Mellitus.
Lp(a) may refine CV risk assessment in T2DM; leaves open its interplay with LDL:HDL ratio and glycemic control.
Lipoprotein-A is a key lipid particle, which are having a key role in cardiovascular diseases and other metabolic disorders.Altered lipid level is mainly seen in patients with Type 2 Diabetes Mellitus with deranged lipid ratios like the low-density lipoprotein to high-density lipoprotein ratio.This narrative review mainly focus on the association of Lipoprotein-A, lowdensity lipoprotein: high-density lipoprotein ratio and glycemic control in Type 2 Diabetes Mellitus Patients.This narrative review focus on the pathophysiologic role of Lipoprotein-A with respect to Type 2 Diabetes Mellitus and cardiovascular diseases, the clinical relevance of increased Lipoprotein-A concentrations in diabetic patients, and treating dyslipidemia in this population.We will appraisal the role of Lipoprotein-A in Type 2 Diabetes Mellitus, potential pathophysiological mechanisms, and treatment options for influencing Lipoprotein-A in Type 2 Diabetes Mellitus patients.In order to understand the better relationship between Lipoprotein-A, lipid ratios (LDL: HDL), and glycemic control in individuals with type 2 diabetes, the study recommends for additional research.
No takes yet. Share an insight, caveat, or question.
A 2026 study conducted a review in Type 2 Diabetes Mellitus. Elevated Lipoprotein(a) vs. Normal Lipoprotein(a) or non-diabetic populations was evaluated on Association between Lipoprotein(a), LDL:HDL ratio, glycemic control, and cardiovascular risk in Type 2 Diabetes Mellitus. Elevated Lipoprotein(a) levels in patients with type 2 diabetes mellitus are associated with increased cardiovascular risk, though the relationship with LDL:HDL ratio and glycemic control remains poorly defined.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: